Ahmad Farshid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ahmad Farshid has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Paul Marley
Department of Cardiology, The Canberra Hospital, Canberra, ACT, Australia
2 shared publications- Ata Doost
Department of Cardiology, Macquarie University Hospital, Macquarie Park, New South Wales, Australia
1 shared publication - Avik Kumar Das
Department of Cardiology, The Canberra Hospital, Canberra, ACT, Australia
1 shared publication B. Nkoane-Kelaeng
The Canberra Hospital, Garran, Australia
1 shared publicationBernd Nowak
1 shared publication- Bruce Shadbolt
Department of Epidemiology, Canberra Hospital, Garran, Australia
1 shared publication
Latest Publications
- 17 January 2025
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 34 (2) , 190-196
The Clinical Significance of PCI-Related Myocardial Infarction in Stable Ischaemic Heart Disease Patients in the Era of hs-Troponin
- 17 January 2025
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 34 (2) , 190-196
The Clinical Significance of PCI-Related Myocardial Infarction in Stable Ischaemic Heart Disease Patients in the Era of hs-Troponin
- Open Access
- 27 November 2020
- Published by Hindawi Limited in Journal of Interventional Cardiology
- Vol. 2020, 1-8
The Rise of Transradial Artery Access for Percutaneous Coronary Intervention in Patients with Acute Coronary Syndromes in Australia
Objectives. The aim of this study was to evaluate the outcomes of acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) via transradial artery access (TRA) or transfemoral artery access (TFA). Background. Over the last decade, evidence for the benefit of TRA for PCI has grown, leading to a steady uptake of TRA around the world. Despite this, the topic remains controversial with contrary evidence to suggest no significant benefit over TFA. Methods. A retrospective study of consecutive ACS patients from 2011 to 2017 who underwent PCI via TRA or TFA. The primary outcome was Major Adverse Cardiovascular Events (MACE), a composite of death, myocardial infarction (MI), target lesion revascularisation (TLR), or coronary artery bypass graft surgery (CABG) at 12 months. Secondary outcomes included Bleeding Academic Research Consortium (BARC) bleeding events scored 2 or higher, haematoma formation, and stent thrombosis, in addition to all individual components of MACE. Results. We treated 3624 patients (77% male), with PCI via TFA (n = 2391) or TRA (n = 1233). Transradial artery access was associated with a reduction in mortality (3% vs 6.3%; ), MI (1.8% vs 3.9%; ), CABG (0.6% vs 1.5%; ), TLR (1% vs 2.9%; ), large haematoma (0.4% vs 1.8%; ), BARC 2 (0.2% vs 1.1%; ), and BARC 3 events (0.4% vs 1.0%; ). On multivariate Cox regression analysis, TFA, age ≥ 75, prior PCI, use of bare metal stents, cardiogenic shock, cardiac arrest, and multivessel coronary artery disease were associated with an increased risk of MACE. Conclusion. Despite the limitations secondary to the observational nature of our study and multiple confounders, our results are in line with results of major trials and, as such, we feel that our results support the use of TRA as the preferred access site in patients undergoing PCI for ACS to improve patient outcomes.
- 27 November 2020
- Published by Hindawi Limited in Journal of Interventional Cardiology
- Vol. 2020, 1-8
Open AccessThe Rise of Transradial Artery Access for Percutaneous Coronary Intervention in Patients with Acute Coronary Syndromes in Australia
Objectives. The aim of this study was to evaluate the outcomes of acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) via transradial artery access (TRA) or transfemoral artery access (TFA). Background. Over the last decade, evidence for the benefit of TRA for PCI has grown, leading to a steady uptake of TRA around the world. Despite this, the topic remains controversial with contrary evidence to suggest no significant benefit over TFA. Methods. A retrospective study of consecutive ACS patients from 2011 to 2017 who underwent PCI via TRA or TFA. The primary outcome was Major Adverse Cardiovascular Events (MACE), a composite of death, myocardial infarction (MI), target lesion revascularisation (TLR), or coronary artery bypass graft surgery (CABG) at 12 months. Secondary outcomes included Bleeding Academic Research Consortium (BARC) bleeding events scored 2 or higher, haematoma formation, and stent thrombosis, in addition to all individual components of MACE. Results. We treated 3624 patients (77% male), with PCI via TFA (n = 2391) or TRA (n = 1233). Transradial artery access was associated with a reduction in mortality (3% vs 6.3%; ), MI (1.8% vs 3.9%; ), CABG (0.6% vs 1.5%; ), TLR (1% vs 2.9%; ), large haematoma (0.4% vs 1.8%; ), BARC 2 (0.2% vs 1.1%; ), and BARC 3 events (0.4% vs 1.0%; ). On multivariate Cox regression analysis, TFA, age ≥ 75, prior PCI, use of bare metal stents, cardiogenic shock, cardiac arrest, and multivessel coronary artery disease were associated with an increased risk of MACE. Conclusion. Despite the limitations secondary to the observational nature of our study and multiple confounders, our results are in line with results of major trials and, as such, we feel that our results support the use of TRA as the preferred access site in patients undergoing PCI for ACS to improve patient outcomes.
- Open Access
- 24 June 2019
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 28, S222
Nurse-Led Protocol-Based Atrial Fibrillation Clinic Associated with High Quality Care for Patients
- 24 June 2019
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 28, S222
Open AccessNurse-Led Protocol-Based Atrial Fibrillation Clinic Associated with High Quality Care for Patients
- 19 September 2016
- Published by AMPCo in Medical Journal of Australia
- Vol. 205 (6) , 258-259
New developments in coronary stent technology
- 19 September 2016
- Published by AMPCo in Medical Journal of Australia
- Vol. 205 (6) , 258-259
New developments in coronary stent technology
- 19 July 2016
- Published by Wiley in Clinical Cardiology
- Vol. 39 (11) , 653-657
Association Between Body Mass Index and Age of Presentation With Symptomatic Coronary Artery Disease
Background: Obesity is increasingly recognized as an important risk factor for coronary artery disease (CAD).Hypothesis: Patients with increased body mass index (BMI) present at a younger age with symptomatic CAD.Methods: We analyzed data on 2137 consecutive patients admitted for treatment of CAD proven on angiography from 2010 to 2013, excluding those with prior coronary intervention or bypass surgery.Results: Mean age was 64.1 ± 12.4 years; 75% were male; 43.6% were overweight (BMI 25–29.9 kg/m2) and 31.6% were obese (BMI ≥30 kg/m2). Patients with BMI ≥25 kg/m2 compared with 2 were more likely to have diabetes (24.5% vs 13.6%), hypertension (56.2% vs 45.5%), and hyperlipidemia (42.4% vs 31.6%; P < 0.0001 for all). On multivariate analysis adjusted for sex and cardiovascular risk factors, patients in higher BMI categories had lower mean age in a linear and stepwise fashion compared with those with normal BMI (P < 0.0001). For example, compared with patients with normal BMI, those with BMI of 35 to 39.9 kg/m2 were on average 9.2 years younger (P < 0.0001). Multivariate analysis examining the interaction between sex and BMI produced similar results for effect of BMI on age of presentation (P = 0.97 for interaction).Conclusions: After multivariate adjustment, patients with increased BMI presented at an earlier age with symptomatic CAD compared with patients with normal BMI. Primary prevention efforts in those with increased BMI to reduce risk‐factor burden, including evidence‐based treatments for weight reduction, promise to reduce risk or delay onset of CAD.
- 19 July 2016
- Published by Wiley in Clinical Cardiology
- Vol. 39 (11) , 653-657
Association Between Body Mass Index and Age of Presentation With Symptomatic Coronary Artery Disease
Background: Obesity is increasingly recognized as an important risk factor for coronary artery disease (CAD).Hypothesis: Patients with increased body mass index (BMI) present at a younger age with symptomatic CAD.Methods: We analyzed data on 2137 consecutive patients admitted for treatment of CAD proven on angiography from 2010 to 2013, excluding those with prior coronary intervention or bypass surgery.Results: Mean age was 64.1 ± 12.4 years; 75% were male; 43.6% were overweight (BMI 25–29.9 kg/m2) and 31.6% were obese (BMI ≥30 kg/m2). Patients with BMI ≥25 kg/m2 compared with 2 were more likely to have diabetes (24.5% vs 13.6%), hypertension (56.2% vs 45.5%), and hyperlipidemia (42.4% vs 31.6%; P < 0.0001 for all). On multivariate analysis adjusted for sex and cardiovascular risk factors, patients in higher BMI categories had lower mean age in a linear and stepwise fashion compared with those with normal BMI (P < 0.0001). For example, compared with patients with normal BMI, those with BMI of 35 to 39.9 kg/m2 were on average 9.2 years younger (P < 0.0001). Multivariate analysis examining the interaction between sex and BMI produced similar results for effect of BMI on age of presentation (P = 0.97 for interaction).Conclusions: After multivariate adjustment, patients with increased BMI presented at an earlier age with symptomatic CAD compared with patients with normal BMI. Primary prevention efforts in those with increased BMI to reduce risk‐factor burden, including evidence‐based treatments for weight reduction, promise to reduce risk or delay onset of CAD.
- 1 August 2007
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 3 (2) , 249-255
A novel ultra-thin bare metal stent (BMS): results from a worldwide registry
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 August 2007
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 3 (2) , 249-255
A novel ultra-thin bare metal stent (BMS): results from a worldwide registry
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)